Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HPGDS | O60760 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2713663 | 0.85 | EPHX2 (0.52) | EPHX2L3MBTL1JMJD6ALDH1A1GABRA5 | |
| SCHEMBL30403546 | 0.85 | EPHX2 (0.52) | EPHX2L3MBTL1JMJD6ALDH1A1GABRA5 | |
| SCHEMBL13875976 | 0.83 | PROKR1 (0.44) | JMJD6MAPT | |
| SCHEMBL796410 | 0.83 | L3MBTL1 (0.60) | EPHX2L3MBTL1JMJD6ALDH1A1GABRA5 | |
| SCHEMBL27913659 | 0.82 | EPHX2 (0.50) | EPHX2L3MBTL1JMJD6ALDH1A1GABRA5 | |
| SCHEMBL30281370 | 0.82 | EPHX2 (0.52) | EPHX2L3MBTL1JMJD6MAPTGSK3B | |
| SCHEMBL13890805 | 0.81 | EPHX2 (0.52) | EPHX2L3MBTL1JMJD6GABRA5MAPT | |
| SCHEMBL13875972 | 0.80 | KCNK3 (0.48) | ALDH1A1GSK3BKDM4ENR2E1 | |
| SCHEMBL31191107 | 0.79 | EPHX2 (0.53) | EPHX2L3MBTL1JMJD6GABRA5MAPT | |
| SCHEMBL22837053 | 0.79 | KCNK3 (0.35) | EPHX2MAPTGSK3BNR2E1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099184-A1 | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099184-A1 | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors | EPHX1, EPHX2, NCEH1 | EPHX2 2/4885L3MBTL1 4642/4885JMJD6 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.